2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮
| 中文名称 | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 |
|---|---|
| 中文同义词 | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮;DPRE1抑制剂(BTZ043);DPRE1抑制剂(PBTZ169);化合物BTZ043;BTZ-043 CHIRALITY手性;化合物BTZ043,10 MM DMSO 溶液;BTZ043试剂;抑制剂BTZ043 |
| 英文名称 | BTZ043 |
| 英文同义词 | BTZ043;BTZ043 raceMate;2-[(2S)-2-Methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one;BTZ 10526043;PBTZ 169;2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one;BTZ043 (BTZ-043;CS-2310 |
| CAS号 | 1161233-85-7 |
| 分子式 | C17H16F3N3O5S |
| 分子量 | 431.39 |
| EINECS号 | |
| 相关类别 | 抑制剂;细胞生物学试剂 |
| Mol文件 | 1161233-85-7.mol |
| 结构式 | ![]() |
2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 性质
| 熔点 | 190-191°C |
|---|---|
| 密度 | 1.68 |
| 储存条件 | -20°C Freezer |
| 溶解度 | 可溶于氯仿(轻微)、甲醇(非常轻微) |
| 形态 | 固体 |
| 颜色 | 白色至浅黄色 |
DprE1.
The MIC of BTZ043 against M. tuberculosis H37Rv and Mycobacterium smegmatis are 1 ng/mL (2.3 nM) and 4 ng/mL (9.2 nM), respectively. The in vitro activity of BTZ043 against 30 Nocardia brasiliensis isolates is also tested. The MIC50 and MIC90 values for BTZ043 are 0.125 and 0.25 μg/mL. The MIC for N. carnea ATCC 6847 is 0.003μg/mL, for N. transvalensis ATCC 6865 is 0.003μg/mL, for N. brasiliensis NCTC10300 is 0.03 μg/mL, and for N. brasiliensis HUJEG-1 is 0.125μg/mL. The MIC value for M. tuberculosis H37Rv is 0.000976 μg/mL. The MIC value of BTZ-043 is >64 μg/mL for Escherichia coli ATCC 25922 and S. aureus ATCC 29213.
Four weeks of treatment with BTZ043 reduces the bacterial burden in the lungs and spleens by 1 and 2 logs, respectively, at the concentrations used. Additional results suggest that BTZ043 efficacy is time-rather than dose-dependent. Acute (5 g/kg) and chronic (25 and 250 mg/kg) toxicology studies in uninfected mice show that, even at the highest dose tested, there are no adverse anatomical, behavioral, or physiological effects after one month.
1344087-80-4
1344087-73-5
1161233-85-7
以2-(甲硫基)-8-硝基-6-(三氟甲基)-4H-苯并[e][1,3]噻嗪-4-酮(化合物1)和(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷为原料,合成2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮的一般步骤如下:将3.0 g化合物1悬浮于15 mL乙醇中,随后加入1.5 g(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷。反应混合物在室温下搅拌后,加热至50-60℃维持20分钟。反应完成后,冷却至室温,加入100 mL水析出淡黄色固体。通过过滤分离产物,产率为76%(基于2-氯-3-硝基-5-三氟甲基苯甲酰胺计算)。
参考文献:
[1] Patent: EP2380886, 2011, A1. Location in patent: Page/Page column 8
[2] Patent: WO2011/132070, 2011, A1. Location in patent: Page/Page column 12-13
安全信息
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/09/15 | HY-13579R | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 BTZ043 (Standard) | 1161233-85-7 | 5 mg | 1600元 |
| 2026/09/15 | HY-13579R | 2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 BTZ043 (Standard) | 1161233-85-7 | 10 mg | 2560元 |
![2-[(2S)-2-甲基-1,4-二氧杂-8-氮杂螺[4.5]癸烷-8-基]-8-硝基-6-三氟甲基-4H-1,3-苯并噻嗪-4-酮 结构式](CAS/20150408/GIF/1161233-85-7.gif)